跳至主要内容
临床试验/NCT06335420
NCT06335420招募中不适用

Polyp Prophylactic Properties of Polyacetylenes in Patients With Previous Polypectomy

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年6月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
2
主要终点
Number and size of recurrent polyps found at the one-year follow up colonoscopy

研究概览

简要总结

The goal of this prospective randomized double-blinded bi-national study is to test the prophylactic effect of polyacetylenes from carrots on the population of patients who had a resection of high-risk adenomas of the large bowel.

The main question it aims to answer is: Will carrot juice rich in polyacetylenes inhibit neoplastic transformation and growth in high-risk humans?

Participants will have to drink 100 ml of juice daily after the adenoma resection for 1 year and keep a simple diary/calendar.

Researchers will compare the group with ingestion of Falcarinol (FaOH) / Falcarindiol (FaDOH) rich carrot juice versus the group consuming placebo juice, to see if the polyacetylenes significantly reduces neoplastic transformation and growth in high-risk patients.

详细描述

The study is a prospective double-blinded randomized controlled trial carried out in four centers: one Danish (Department of Surgery, Odense University Hospital - OUH) and five Swedish (Ersta Hospital - EH, Stockholm; Karolinska University Hospital - KUH, Stockholm; Uppsala University Hospital - UUH, Uppsala; Sahlgrenska University Hospital - SUH, Goteborg, Capio St. Gorans Hospital - CSH, Stockholm).

The investigators will organize two parallel arms of 400 patients: an intervention arm (consumption of 100 ml active carrot juice daily) and a control arm (consumption of 100 ml placebo juice daily) in a 1:1 randomized allocation ratio for 1 year. The project is structured in 2 working packages (WP):

  1. The clinical trial (including cultivation and quality control of carrots and juice production; quantification of FaOH and FaDOH in the carrot and the placebo juice and the randomized trial)
  2. The assessment of patient compliance and ways to improve it (Umeå Institute of Design, Umeå University - UMU).

The investigators hypothesize that the difference between the active arm (carrot juice) and the control arm (placebo juice) measured by number and growth rate (size) of recurrent adenomas will mediate a 20% reduction or larger in both size and number.

Outcomes will be investigated through standard colonoscopy report, questionnaires, calendars and diaries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any type of resection for adenomas larger than 20 mm in size (endoscopically evaluated) or endoscopically resected T1 cancers.
  • Acceptance of the treatment and follow-up program.
  • Capability to understand and follow the instructions.

排除标准

  • Patients allocated to "high-risk" group because of many small polyps (>4).
  • Known relevant allergies.
  • Chronic consumption of COX (cyclooxygenase) inhibitors (Aspirin, Celecoxib, Ibuprofen, Diclofenac, Ketoprofen, Ketorolac, Indometacin, Naproxen, Piroxicam) or immunosuppressive agents (Methotrexate, Azathioprine or glucocorticoids).
  • Patients with different neoplastic disease under treatment (Chemo-/Radio-/Imunotherapy).
  • Severe comorbidity NYHA III-IV.
  • Lynch syndrome.

结局指标

主要结局

Number and size of recurrent polyps found at the one-year follow up colonoscopy

时间窗: 1 year

The combined endpoint (number x size of recurrent polyps) after 1 year of treatment.

次要结局

  • Polyp number and mean size per patient and the relation with the carrot consumption measurement(1 year)
  • Compliance rate (Juice consumption level) and side effects(1 year)
  • The number of polyps with low, medium, high degree of dysplasia and cancer(1 year)
  • Acceptability of treatment(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验